Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lirentelimab for severe and chronic forms of allergic conjunctivitis.
Anesi SD, Tauber J, Nguyen QD, Chang P, Berdy GJ, Lin CC, Chu DS, Levine HT, Fernandez AD, Roy N, Asbell PA, Kantor AM, Chang AT, Singh B, Youngblood BA, Jeng BH, Jhanji V, Rasmussen HS, Foster CS. Anesi SD, et al. Among authors: berdy gj. J Allergy Clin Immunol. 2022 Sep;150(3):631-639. doi: 10.1016/j.jaci.2022.03.021. Epub 2022 Apr 4. J Allergy Clin Immunol. 2022. PMID: 35390403 Free article. Clinical Trial.
Allergic conjunctivitis: a survey of new antihistamines.
Berdy GJ, Abelson MB, George MA, Smith LM, Giovanoni RL. Berdy GJ, et al. J Ocul Pharmacol. 1991 Winter;7(4):313-24. doi: 10.1089/jop.1991.7.313. J Ocul Pharmacol. 1991. PMID: 1687324 Clinical Trial.
Pemirolast potassium 0.1% ophthalmic solution is an effective treatment for allergic conjunctivitis: a pooled analysis of two prospective, randomized, double-masked, placebo-controlled, phase III studies.
Abelson MB, Berdy GJ, Mundorf T, Amdahl LD, Graves AL; Pemirolast study group. Abelson MB, et al. Among authors: berdy gj. J Ocul Pharmacol Ther. 2002 Oct;18(5):475-88. doi: 10.1089/10807680260362759. J Ocul Pharmacol Ther. 2002. PMID: 12419098 Clinical Trial.
31 results